Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission.
作者信息
Kuhn Louise, Sinkala Moses, Kankasa M P H Chipepo, Kasonde Prisca, Thea Donald M, Aldrovandi Grace M
出版信息
J Acquir Immune Defic Syndr. 2006 Jun;42(2):260-2. doi: 10.1097/01.qai.0000214820.26281.df.
Abstract
摘要
相似文献
1
Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission.
J Acquir Immune Defic Syndr. 2006 Jun;42(2):260-2. doi: 10.1097/01.qai.0000214820.26281.df.
2
Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India.
Indian J Pathol Microbiol. 2011 Apr-Jun;54(2):359-61. doi: 10.4103/0377-4929.81637.
3
Characterization of nevirapine (NVP) resistance mutations and HIV type 1 subtype in women from Abidjan (Côte d'Ivoire) after NVP single-dose prophylaxis of HIV type 1 mother-to-child transmission.
AIDS Res Hum Retroviruses. 2005 Dec;21(12):1031-4. doi: 10.1089/aid.2005.21.1031.
4
Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.
AIDS Res Hum Retroviruses. 2005 Apr;21(4):319-24. doi: 10.1089/aid.2005.21.319.
5
[Drug resistance of HIV-1 as a result of using nevirapine for chemoprophylaxis of vertical viral transmission from HIV-infected mother to infant].
Vopr Virusol. 2009 Jan-Feb;54(1):45-8.
6
Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention.
AIDS Res Hum Retroviruses. 2009 Nov;25(11):1099-106. doi: 10.1089/aid.2009.0088.
7
Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.
AIDS Res Hum Retroviruses. 2004 Jun;20(6):595-9. doi: 10.1089/0889222041217518.
8
Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.
Antivir Ther. 2011;16(1):109-13. doi: 10.3851/IMP1698.
9
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
AIDS. 2001 Oct 19;15(15):1951-7. doi: 10.1097/00002030-200110190-00006.
10
[Maternal and neonatal drug resistance].
Vopr Virusol. 2011 Sep-Oct;56(5):47-9.
引用本文的文献
1
Pretreatment and Acquired Drug Resistance in Children With Human Immunodeficiency Virus Type 1 in Jos, Nigeria.
Open Forum Infect Dis. 2024 Feb 19;11(3):ofae092. doi: 10.1093/ofid/ofae092. eCollection 2024 Mar.
2
HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine.
AIDS. 2011 Jul 31;25(12):1461-9. doi: 10.1097/QAD.0b013e3283492180.
3
Reuse of single-dose nevirapine in subsequent pregnancies for the prevention of mother-to-child HIV transmission in Lusaka, Zambia: a cohort study.
BMC Infect Dis. 2008 Dec 30;8:172. doi: 10.1186/1471-2334-8-172.
4
Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission.
J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):472-8. doi: 10.1097/qai.0b013e3181594c1c.
本文引用的文献
1
Issues in the design of a clinical trial with a behavioral intervention--the Zambia exclusive breast-feeding study.
Control Clin Trials. 2004 Aug;25(4):353-65. doi: 10.1016/j.cct.2004.06.005.
2
Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.
N Engl J Med. 2004 Jul 15;351(3):229-40. doi: 10.1056/NEJMoa041305. Epub 2004 Jul 9.
3
Low frequency of the V106M mutation among HIV-1 subtype C-infected pregnant women exposed to nevirapine.
AIDS. 2003 Jul 25;17(11):1698-700. doi: 10.1097/00002030-200307250-00017.
4
Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance.
J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):216-29. doi: 10.1097/00042560-200206010-00011.
5
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
AIDS. 2001 Oct 19;15(15):1951-7. doi: 10.1097/00002030-200110190-00006.
6
Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).
J Infect Dis. 2001 Oct 1;184(7):914-7. doi: 10.1086/323153. Epub 2001 Aug 13.
Zotero 插件